On January 9, 2007, the U.S. Supreme Court opened the door to allowing a party to challenge the validity of a patent that it has licensed from the patent’s owner. MedImmune, Inc. v. Genentech, Inc., No. 05-608, slip op. (Jan. 9, 2007).
Read the complete article by clicking on the link below.
Read the complete article by clicking on the link below.
Related Insights
May 22, 2026
Foley Viewpoints
New Lawsuit Tests the Limits of Donor-Advised Fund Advisory Privileges
A recent lawsuit seeking to clarify the extent of an advisor’s privileges with respect to a donor-advised fund (DAF) has been filed in…
May 22, 2026
Energy Current
FERC Just Rewrote the Rules for Natural Gas Infrastructure. Here’s What It Means.
Yesterday’s unanimous FERC vote is the most significant natural gas permitting reform in two decades — and its practical implications…
May 22, 2026
Foley Viewpoints
What the Federal Circuit’s Poultry Patent Ruling Says About 'About'
The decision does not appear to prohibit the use of terms such as "about" or "approximately." Rather, it reinforces that such terms may be acceptable where the patent record provides sufficient context for understanding the scope of the claimed range.